Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy and safety of a fixed combination of
Brinzolamide/Brimonidine in lowering intraocular pressure (IOP) relative to each of its
individual active components in patients with open-angle glaucoma and/or ocular hypertension.